Latest | F'cast | |
---|---|---|
Div Yield | 1.9% | 0.0% |
Div Cover | 1.3 | 2.6 |
Op Mrgn | 17.9% | 29.8% |
ROCE | 62.6% |
Latest | F'cast | |
---|---|---|
P/E | 40.5 | 19.2 |
PEG | 0.5 | 0.2 |
Pr/Revenue | 5.3 | 3.6 |
Pr/Book | 6.1 |
Latest | F'cast | |
---|---|---|
Revenue | 3.3% | -12.4% |
PBT | 175.8% | 73.3% |
EPS | 81.1% | 113.2% |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 24,384.00 | 1,548.00 | 103.00¢ | 95.0 | n/a | -39% | 280.00¢ | 2.9% |
31-Dec-20 | 26,617.00 | 3,916.00 | 244.00¢ | 38.6 | 0.3 | +137% | 280.00¢ | 3.0% |
31-Dec-21 | 37,417.00 | (265.00) | 8.00¢ | 1,395.8 | n/a | -97% | 287.00¢ | 2.6% |
31-Dec-22 | 44,351.00 | 2,501.00 | 212.00¢ | 68.1 | 0.0 | +2,550% | 290.00¢ | 2.0% |
31-Dec-23 | 45,811.00 | 6,899.00 | 384.00¢ | 35.5 | 0.4 | +81% | 290.00¢ | 2.1% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 51,631.28 | 15,388.09 | 632.93p | 19.1 | 0.2 | +113% | 240.66p | 0.0% |
31-Dec-25 | 55,425.89 | 17,661.62 | 724.27p | 16.7 | 1.2 | +14% | 252.70p | 0.0% |
31-Dec-26 | 58,406.01 | 19,887.11 | 785.04p | 15.4 | 1.8 | +8% | 264.67p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
ODAC reviewed Imfinzi in resectable lung cancer | 26-Jul-2024 | 07:00 | RNS |
Half-year Report | 25-Jul-2024 | 07:00 | RNS |
Acquisition of Amolyt Pharma completed | 15-Jul-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 12,180.00p |
Change Today | 120.00p |
% Change | 1.00 % |
52 Week High | 12,600.00p |
52 Week Low | 9,501.00p |
Volume | 1,495,839 |
Shares Issued | 1,550.27m |
Market Cap | £188,823m |
RiskGrade | 123 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 9 |
Buy | 15 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 1 |
Total | 30 |
Latest | Previous | |
---|---|---|
1st Interim | 2nd Interim | |
Ex-Div | 08-Aug-24 | 22-Feb-24 |
Paid | 09-Sep-24 | 25-Mar-24 |
Amount | 100.00¢ | 197.00¢ |
Time | Volume / Share Price |
16:49 | 19 @ 12,180.00p |
16:35 | 774 @ 12,180.00p |
16:35 | 296 @ 12,180.00p |
16:35 | 53 @ 12,180.00p |
16:35 | 138 @ 12,180.00p |
You are here: research